330 related articles for article (PubMed ID: 36432736)
1.
Luu TG; Kim HK
Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36432736
[TBL] [Abstract][Full Text] [Related]
2. Recent developments on PET radiotracers for TSPO and their applications in neuroimaging.
Zhang L; Hu K; Shao T; Hou L; Zhang S; Ye W; Josephson L; Meyer JH; Zhang MR; Vasdev N; Wang J; Xu H; Wang L; Liang SH
Acta Pharm Sin B; 2021 Feb; 11(2):373-393. PubMed ID: 33643818
[TBL] [Abstract][Full Text] [Related]
3. Mapping of Translocator Protein (18 kDa) in Peripheral Sterile Inflammatory Disease and Cancer through PET Imaging.
Adhikari A; Singh P; Mahar KS; Adhikari M; Adhikari B; Zhang MR; Tiwari AK
Mol Pharm; 2021 Apr; 18(4):1507-1529. PubMed ID: 33645995
[TBL] [Abstract][Full Text] [Related]
4. [
Kim K; Kim H; Bae SH; Lee SY; Kim YH; Na J; Lee CH; Lee MS; Ko GB; Kim KY; Lee SH; Song IH; Cheon GJ; Kang KW; Kim SE; Chung JK; Kim EE; Paek SH; Lee JS; Lee BC; Youn H
Theranostics; 2020; 10(20):9315-9331. PubMed ID: 32802194
[TBL] [Abstract][Full Text] [Related]
5.
Chaney A; Cropper HC; Johnson EM; Lechtenberg KJ; Peterson TC; Stevens MY; Buckwalter MS; James ML
J Nucl Med; 2019 Jan; 60(1):122-128. PubMed ID: 29976695
[TBL] [Abstract][Full Text] [Related]
6. Detection of Alzheimer's disease-related neuroinflammation by a PET ligand selective for glial versus vascular translocator protein.
Ji B; Ono M; Yamasaki T; Fujinaga M; Zhang MR; Seki C; Aoki I; Kito S; Sawada M; Suhara T; Sahara N; Higuchi M
J Cereb Blood Flow Metab; 2021 Aug; 41(8):2076-2089. PubMed ID: 33557690
[TBL] [Abstract][Full Text] [Related]
7. Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders.
Werry EL; Bright FM; Piguet O; Ittner LM; Halliday GM; Hodges JR; Kiernan MC; Loy CT; Kril JJ; Kassiou M
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261683
[TBL] [Abstract][Full Text] [Related]
8. Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging in Neurological Diseases.
Alam MM; Lee J; Lee SY
Nucl Med Mol Imaging; 2017 Dec; 51(4):283-296. PubMed ID: 29242722
[TBL] [Abstract][Full Text] [Related]
9. Essential Principles and Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging.
Viviano M; Barresi E; Siméon FG; Costa B; Taliani S; Da Settimo F; Pike VW; Castellano S
Curr Med Chem; 2022 Aug; 29(28):4862-4890. PubMed ID: 35352645
[TBL] [Abstract][Full Text] [Related]
10. Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases.
Dupont AC; Largeau B; Santiago Ribeiro MJ; Guilloteau D; Tronel C; Arlicot N
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387722
[TBL] [Abstract][Full Text] [Related]
11. An update into the medicinal chemistry of translocator protein (TSPO) ligands.
Barresi E; Robello M; Costa B; Da Pozzo E; Baglini E; Salerno S; Da Settimo F; Martini C; Taliani S
Eur J Med Chem; 2021 Jan; 209():112924. PubMed ID: 33081988
[TBL] [Abstract][Full Text] [Related]
12. Preclinical evaluation of (S)-[
Ramakrishnan NK; Hird M; Thompson S; Williamson DJ; Qiao L; Owen DR; Brooks AF; Scott PJH; Bacallado S; O'Brien JT; Aigbirhio FI
Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):125-136. PubMed ID: 34405276
[TBL] [Abstract][Full Text] [Related]
13. Recent progress on the development of fluorescent probes targeting the translocator protein 18 kDa (TSPO).
Wongso H
Anal Biochem; 2022 Oct; 655():114854. PubMed ID: 35963341
[TBL] [Abstract][Full Text] [Related]
14. Imaging neuroinflammation with TSPO: A new perspective on the cellular sources and subcellular localization.
Guilarte TR; Rodichkin AN; McGlothan JL; Acanda De La Rocha AM; Azzam DJ
Pharmacol Ther; 2022 Jun; 234():108048. PubMed ID: 34848203
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal evaluation of neuroinflammation and oxidative stress in a mouse model of Alzheimer disease using positron emission tomography.
Rejc L; Gómez-Vallejo V; Joya A; Arsequell G; Egimendia A; Castellnou P; Ríos-Anglada X; Cossío U; Baz Z; Iglesias L; Capetillo-Zarate E; Ramos-Cabrer P; Martin A; Llop J
Alzheimers Res Ther; 2022 Jun; 14(1):80. PubMed ID: 35676734
[TBL] [Abstract][Full Text] [Related]
16. The methodology of TSPO imaging with positron emission tomography.
Turkheimer FE; Rizzo G; Bloomfield PS; Howes O; Zanotti-Fregonara P; Bertoldo A; Veronese M
Biochem Soc Trans; 2015 Aug; 43(4):586-92. PubMed ID: 26551697
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of translocator 18 kDa protein (TSPO) positron emission tomography (PET) radioligands with low binding sensitivity to human single nucleotide polymorphism rs6971.
Zanotti-Fregonara P; Zhang Y; Jenko KJ; Gladding RL; Zoghbi SS; Fujita M; Sbardella G; Castellano S; Taliani S; Martini C; Innis RB; Da Settimo F; Pike VW
ACS Chem Neurosci; 2014 Oct; 5(10):963-71. PubMed ID: 25123416
[TBL] [Abstract][Full Text] [Related]
18. TSPO imaging in animal models of brain diseases.
Van Camp N; Lavisse S; Roost P; Gubinelli F; Hillmer A; Boutin H
Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):77-109. PubMed ID: 34245328
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Evaluation of a Novel TSPO PET Ligand 2-(7-Butyl-2-(4-(2-[
Tang D; Li J; Nickels ML; Huang G; Cohen AS; Manning HC
Mol Imaging Biol; 2019 Feb; 21(1):113-121. PubMed ID: 29869061
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
